As much as I like your research Frangi, please show the same courtesy as you would expect from others on this forum, namely, I asked you a question a number of weeks ago, but you chose not to respond, now for someone whom likes to comment on other posters, for good or bad, can you give me and others your view on how you personally think Brainchip is tracking towards a successful outcome...going by the amount of time you spend in showcasing facts, you must have formed an opinion one way or another.
Be assured, Australians only Sue if you are caught out lying... appreciate an honest response this time !
Best regards....Texta

Hi
@TECH,
so you asked me for an honest response to your question how I “personally think BrainChip is tracking towards a successful outcome”?
Voilà: Well, I believe the successful outcome that all of us genuine shareholders hope for will ultimately depend on an interplay of multiple factors, but primarily on the capability of our management to convert the apparently super-high customer interest (if we are to believe our CEO) into more actual sales.
My BrainChip journey over the past 3.5 years has convinced me that the tech is real and has been and continues to be validated by researchers in both academia and industry all over the world. At the same time, though, it has taught me that the adoption of neuromorphic technology is taking much longer than anticipated.
The amount of time I voluntarily dedicate to this forum and the content I contribute should give you a hint that I’m optimistic in principle, yet not uncritical of our company. I haven’t sold a single of my BRN shares - on the contrary, I’ve been accumulating ever since I first bought in. However, I would definitely not go as far as claim that BrainChip had reached its tipping point and that I personally no longer see any risk, like FF did back in March 2024. Just recall the financial predicament our partner Prophesee found themselves in about a year ago - and they were much further advanced on their commercialisation path than we currently are.
There’s a limit to what my and anyone else’s sleuthing and dot-joining can tell us about a future “successful outcome”.
After all, we are not privy to knowing what’s going on behind closed doors, whether there are currently any prospective customers about to sign on the dotted line to generate much needed revenue for our company, how many NDAs are currently in place and how many of those will eventually translate into a deal beyond initial evaluation.
None of us without insider knowledge can predict whether our company’s roadmap will go ahead as planned (which would be awesome), how our non-neuromorphic and neuromorphic competitors in the Edge AI space will develop over the next few years and how many downselections we will or we won’t make because of them, which employees will leave us and why, what exceptional new talents we will be able to attract, how global politics will play out and how world markets will react, what effect certain decisions taken by our management will have on the BRN share price, whether or not BrainChip will be acquired one day etc.
All these and other hard or impossible to predict factors may play a role to a larger or lesser extent. Excellent technology alone does not guarantee a “successful outcome” in a commercial sense.
Yes, the groundwork has been laid, the ecosystem is being built, and the validation by others is highly encouraging. But “successful” also means that more deals generating meaningful revenue need to follow at some point. And so we wait. Understandably, patience is wearing thin for many long-term holders, especially those whose age and/or health realistically means they cannot afford to wait for much longer, if they themselves - and not their children and grandchildren, if they even have any - would like to enjoy the juicy fruit they have been hoping to harvest.
Yet, some frustrated posters blame BRN management only and overlook the fact that it was also fellow forum users here and elsewhere that have been creating unrealistic expectations and hype over the years for which the company cannot be made solely responsible. My BrainChip journey has also been an intriguing psychology class about the world of echo chambers.
Maybe that’s not exactly the response you wanted to hear from me, but I’m afraid I can’t answer your question in a more honest way than that.
Now before you had initially asked me your question the other day, I had actually asked you to please provide proof to support your claim that there are Accenture patents that do not refer to Loihi as a “neuromorphic
research chip” at some point in the patent.
So since it was you who brought up the topic of courtesy yourself, please now also have the courtesy to respond to me on that matter. I won’t frame it the same way as you did with me, though, by claiming you chose not to respond, but instead will give you the benefit of doubt that it may have merely slipped your mind.
Best regards
Frangipani

️

️